Objective: To explore the neuroprotective potential of hesperidin in rats that have been exposed to propionic acid-induced autism and correlation assessment analysis with serum BDNF levels, a biomarker for neuroprotection.
Methodology: The study included 25 healthy male 7 weeks-old Sprague-Dawley rats and five groups were designed. Group I included physiological rats (n=5) that were not induced, while the other groups (n=20) received intraperitoneal injections of propionic acid (250 mg/kg/day) for 5 days. Group II was exclusively made up of rats that had been induced with PPA. Groups III, IV, and V involved the rats that were given different dosages of hesperidin (100 mg/kg, 200 mg/kg, and 400 mg/kg, respectively) mixed into their diet for a 24-day period. Hesperidin effects were assessed by measuring BDNF levels via ELISA kits. One-way ANOVA (post hoc Tukeys test) were used in statistical analysis.
Results: Significant recovery of serum BDNF levels was seen in the Hesperidin treated groups (III, IV and V) relative to the PPA-induced group (II). Hesperidin therapy greatly reduced autism-like problems. The measured BDNF levels (ng/ml) were as Group I (15.2±0.5), II (6.8±0.4), III (10.3±0.5), IV (13.0±0.6) and V (14.7±0.5). Significant differences between the groups were found using a one-way ANOVA (p
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
